Report: DR-TB drugs under the microscope, 4th edition

This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs.

We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to standardised questionnaires and the Global TB Drug Facility website.

REPORT UPDATE JULY 2016: This report was published in March 2016, just before the Stop TB Partnership’s Global Drug Facility was due to update its price list for DR-TB drugs.